This HTML5 document contains 108 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.2337/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37364958
rdf:type
wikibase:Item
schema:description
videnskabelig artikel vědecký článek article científic vetenskaplig artikel artículu científicu espublizáu en 2009 vedecký článok наукова стаття, опублікована в червні 2009 wetenschappelijk artikel مقالة علمية نشرت في 23 يونيو 2009 artigo científico scientific article published on 23 June 2009 articolo scientifico bilimsel makale article scientifique wissenschaftlicher Artikel научни чланак
p:P577
wds:Q37364958-67F5B266-CD7F-46C9-8CCB-BAC1BFECD301
wdt:P577
2009-06-23T00:00:00Z
p:P407
wds:Q37364958-03E72D4B-FBB3-4267-86F0-8BEADA1B1BD8
wdt:P407
wd:Q1860
p:P2860
wds:Q37364958-FFB9911F-DCD7-45E7-BA17-CF817FD629AE wds:Q37364958-029BDD81-81F6-4C79-929A-ABE20C0C7076 wds:Q37364958-0CBD90F9-AF1A-436A-8AA7-79AB0EBC4C50 wds:Q37364958-20153D68-1CDA-454E-8E94-4E4831149148 wds:Q37364958-72E9E795-E9CD-4217-9F41-047BC1399C82 wds:Q37364958-4C060D4A-BB70-482F-9193-35BB09595217 wds:Q37364958-A20A9874-58DB-46F2-8D87-3E7648FF41F6 wds:Q37364958-7A00C11F-B480-4FA9-AB18-45C0C2E8F9C8 wds:Q37364958-7F280936-A796-41E8-9A00-FC0272DE62E6 wds:Q37364958-C9151E57-2B18-48DA-8A9F-FD5633EF18A3 wds:Q37364958-F92CBBEE-7D88-4D91-ADF0-19586075477D wds:Q37364958-AFD006AD-0ADA-47EF-A4C7-1B0E9F77A5A3 wds:Q37364958-B3025776-F892-4642-9DAC-3D47A6DA464C wds:Q37364958-B3F0D419-8E88-4761-A18F-008BD855CBF4 wds:Q37364958-BD417396-E572-40BA-A20C-92CEA092FE22
wdt:P2860
wd:Q77963867 wd:Q36079991 wd:Q35505939 wd:Q44932416 wd:Q77719374 wd:Q40500008 wd:Q54032399 wd:Q61651685 wd:Q68074721 wd:Q45262215 wd:Q77301607 wd:Q79386869 wd:Q36933690 wd:Q73857667 wd:Q35768676
p:P2093
wds:Q37364958-F9D3D32B-FFF2-4D19-A507-4DDFC4F4B1FB wds:Q37364958-58E43945-F7F2-4BB5-9FA3-31E9C1F81A98 wds:Q37364958-5102EBB2-428A-413C-881A-A6F4D8900424 wds:Q37364958-788BE980-528C-4C6F-A132-444BC07177EE wds:Q37364958-2AE8385A-2CFE-4E93-BC9D-89099098838D wds:Q37364958-27F542BE-7A9E-4E48-B0CB-14EB1AB18FC1
wdt:P2093
Bart O Roep Bart Keymeulen Volkert Huurman Bart Van der Auwera Frans Gorus Brigitte Decallonne
rdfs:label
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies
skos:prefLabel
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies
schema:name
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies
p:P50
wds:Q37364958-016A27C8-A79C-4DB1-A4F4-C66957691BCD wds:Q37364958-FD87DF60-7E46-4BDA-ACA1-A99528942431 wds:Q37364958-EC4D1873-1134-4F93-9AC8-AEC0EF192146 wds:Q37364958-678E0CB4-5C23-4B0E-A52B-8F763206F52D
wdt:P50
wd:Q56811703 wd:Q41518360 wd:Q54656098 wd:Q64358610
p:P1476
wds:Q37364958-099801AA-2B21-4872-8486-7080D1A401A7
wdt:P1476
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies
p:P304
wds:Q37364958-F75E5812-90DE-4978-9EF0-04FDC0939D9B
wdt:P304
1817-1819
p:P31
wds:Q37364958-7B314EC5-0912-47EB-9ACF-C082A04FD00D
wdt:P31
wd:Q13442814
p:P921
wds:Q37364958-7FF16A82-28B2-4395-AD47-795F8100276C
wdt:P921
wd:Q785022
p:P698
wds:Q37364958-114D02DD-92F1-4950-B88D-9B2517393AD4
wdtn:P698
n11:19549735
wdt:P698
19549735
p:P1433
wds:Q37364958-35D1A207-B14C-4613-90C5-358B94AF5137
wdt:P1433
wd:Q5270111
p:P433
wds:Q37364958-A642429C-9D43-46B6-9164-86323BC2D35C
p:P478
wds:Q37364958-219D9528-3300-4862-BBE2-A187739A8BF3
wdt:P433
10
wdt:P478
32
p:P356
wds:Q37364958-6C5CAC50-5CAC-47D3-9713-B8A402EBF116
wdtn:P356
n12:DC08-2339
wdt:P356
10.2337/DC08-2339
p:P275
wds:Q37364958-5316f281-065a-4048-b12d-e179e02ad311
p:P6216
wds:Q37364958-aa1efaea-24b8-4d37-8825-33d3cb3e78c7
wdt:P275
wd:Q19125045
wdt:P6216
wd:Q50423863
p:P5875
wds:Q37364958-261E1483-A1D0-4887-9F4E-C382F6859676
wdt:P5875
26314191
p:P932
wds:Q37364958-94B022CB-17DE-4808-8B0F-E9DD91D8D3F4
wdt:P932
2752930